Perrigo Cost of Goods Sold 2010-2024 | PRGO
Perrigo cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
| Perrigo Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2023 | $2,975 |
| 2022 | $2,996 |
| 2021 | $2,723 |
| 2020 | $2,593 |
| 2019 | $2,436 |
| 2018 | $2,900 |
| 2017 | $2,967 |
| 2016 | $3,229 |
| 2015 | $1,553 |
| 2015 | $2,583 |
| 2014 | $2,462 |
| 2013 | $2,260 |
| 2012 | $2,078 |
| 2011 | $1,810 |
| 2010 | $1,522 |
| 2009 | $1,408 |
| Perrigo Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024-09-30 | $683 |
| 2024-06-30 | $671 |
| 2024-03-31 | $724 |
| 2023-12-31 | $730 |
| 2023-09-30 | $713 |
| 2023-06-30 | $765 |
| 2023-03-31 | $768 |
| 2022-12-31 | $773 |
| 2022-09-30 | $737 |
| 2022-06-30 | $750 |
| 2022-03-31 | $737 |
| 2021-12-31 | $743 |
| 2021-09-30 | $706 |
| 2021-06-30 | $632 |
| 2021-03-31 | $642 |
| 2020-12-31 | $669 |
| 2020-09-30 | $633 |
| 2020-06-30 | $602 |
| 2020-03-31 | $690 |
| 2019-12-31 | $214 |
| 2019-09-30 | $778 |
| 2019-06-30 | $718 |
| 2019-03-31 | $726 |
| 2018-12-31 | $752 |
| 2018-09-30 | $708 |
| 2018-06-30 | $715 |
| 2018-03-31 | $724 |
| 2017-12-31 | $770 |
| 2017-09-30 | $734 |
| 2017-06-30 | $733 |
| 2017-03-31 | $730 |
| 2016-12-31 | $844 |
| 2016-09-30 | $777 |
| 2016-06-30 | $794 |
| 2016-03-31 | $814 |
| 2015-12-31 | $-597 |
| 2015-09-30 | $738 |
| 2015-06-30 | $814 |
| 2015-03-31 | $598 |
| 2014-12-31 | $688 |
| 2014-09-30 | $630 |
| 2014-06-30 | |
| 2014-03-31 | $689 |
| 2013-12-31 | $618 |
| 2013-09-30 | $577 |
| 2013-06-30 | |
| 2013-03-31 | $588 |
| 2012-12-31 | $576 |
| 2012-09-30 | $485 |
| 2012-06-30 | |
| 2012-03-31 | $499 |
| 2011-12-31 | $543 |
| 2011-09-30 | $498 |
| 2011-06-30 | |
| 2011-03-31 | $452 |
| 2010-12-31 | $468 |
| 2010-09-30 | $427 |
| 2010-06-30 | |
| 2010-03-31 | $350 |
| 2009-12-31 | $385 |
| 2009-09-30 | $365 |
| 2009-06-30 | |
| 2009-03-31 | $356 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.547B | $4.656B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $196.757B | 25.10 |
| Stryker (SYK) | United States | $136.750B | 30.82 |
| Boston Scientific (BSX) | United States | $131.731B | 37.87 |
| EssilorLuxottica (ESLOY) | France | $109.710B | 0.00 |
| Medtronic (MDT) | Ireland | $102.865B | 15.28 |
| Haleon (HLN) | United Kingdom | $42.732B | 27.76 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.382B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $35.810B | 18.57 |
| ResMed (RMD) | United States | $33.540B | 27.56 |
| Terumo (TRUMY) | Japan | $28.681B | 40.51 |
| Koninklijke Philips (PHG) | Netherlands | $23.480B | 17.97 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.795B | 13.24 |
| Insulet (PODD) | United States | $18.017B | 71.75 |
| Baxter (BAX) | United States | $14.940B | 9.72 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.667B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.606B | 38.65 |
| Bio-Rad Laboratories (BIO) | United States | $9.131B | 31.03 |
| Demant (WILYY) | Denmark | $8.251B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.174B | 14.35 |
| Haemonetics (HAE) | United States | $3.938B | 19.22 |
| ICU Medical (ICUI) | United States | $3.868B | 36.83 |
| Prestige Consumer Healthcare (PBH) | United States | $3.840B | 19.10 |
| Envista Holdings (NVST) | United States | $3.289B | 24.50 |
| QuidelOrtho (QDEL) | United States | $3.029B | 19.50 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.863B | 18.36 |
| Neogen (NEOG) | United States | $2.587B | 29.85 |
| LeMaitre Vascular (LMAT) | United States | $2.057B | 49.98 |
| Green Thumb Industries (GTBIF) | United States | $1.724B | 30.17 |
| AtriCure (ATRC) | United States | $1.482B | 0.00 |
| InMode (INMD) | Israel | $1.424B | 8.57 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.386B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.305B | 9.33 |
| BioLife Solutions (BLFS) | United States | $1.214B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.066B | 0.00 |
| Owens & Minor (OMI) | United States | $0.991B | 7.74 |
| CeriBell (CBLL) | United States | $0.926B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.840B | 14.81 |
| Evolus (EOLS) | United States | $0.704B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.680B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.594B | 26.20 |
| Omeros (OMER) | United States | $0.570B | 0.00 |
| Surmodics (SRDX) | United States | $0.567B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.502B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.463B | 0.00 |
| Quanterix (QTRX) | United States | $0.415B | 0.00 |
| Valneva SE (VALN) | France | $0.384B | 0.00 |
| ZimVie (ZIMV) | United States | $0.382B | 32.16 |
| Biote (BTMD) | United States | $0.328B | 7.18 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.11 |
| Canopy Growth (CGC) | Canada | $0.314B | 0.00 |
| Cerus (CERS) | United States | $0.292B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.289B | 0.00 |
| High Tide (HITI) | Canada | $0.269B | 110.67 |
| OraSure Technologies (OSUR) | United States | $0.264B | 17.70 |
| Zynex (ZYXI) | United States | $0.249B | 52.07 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.208B | 14.37 |
| MacroGenics (MGNX) | United States | $0.207B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
| Brainsway (BWAY) | Israel | $0.180B | 95.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.152B | 0.00 |
| Jin Medical (ZJYL) | China | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.59 |
| Quipt Home Medical (QIPT) | United States | $0.125B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.79 |
| Veru (VERU) | United States | $0.095B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.072B | 37.00 |
| Jushi Holdings (JUSHF) | United States | $0.065B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.060B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Exagen (XGN) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
| Modular Medical (MODD) | United States | $0.049B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Safety Shot (SHOT) | United States | $0.045B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.027B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Nephros (NEPH) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.84 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |